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NF-jB Accumulation Associated with COL1A1
Transactivators Defects during Chronological
Aging Represses Type I Collagen Expression
through a 112/61-bp Region of the COL1A1
Promoter in Human Skin Fibroblasts
Nicolas Bigot1, Gallic Beauchef1, Magalie Hervieu1, Thierry Oddos2, Magali Demoor1,
Karim Boumediene1 and Philippe Gale´ra1
The aging process, especially of the skin, is governed by changes in the epidermal, dermo-epidermal, and
dermal compartments. Type I collagen, which is the major component of dermis extracellular matrix (ECM),
constitutes a prime target for intrinsic and extrinsic aging-related alterations. In addition, under the aging
process, pro-inflammatory signals are involved and collagens are fragmented owing to enhanced matrix
metalloproteinase activities, and fibroblasts are no longer able to properly synthesize collagen fibrils. Here, we
demonstrated that low levels of type I collagen detected in aged skin fibroblasts are attributable to an inhibition
of COL1A1 transcription. Indeed, on one hand, we observed decreased binding activities of specific proteins 1
and 3, CCAAT-binding factor, and human collagen-Kru¨ppel box, which are well-known COL1A1 transactivators
acting through the 112/61-bp promoter sequence. On the other hand, the aging process was accompanied
by elevated amounts and binding activities of NF-kB (p65 and p50 subunits), together with an increased number
of senescent cells. The forced expression of NF-kB performed in young fibroblasts was able to establish an old-
like phenotype by repressing COL1A1 expression through the short 112/61-bp COL1A1 promoter and by
elevating the senescent cell distribution. The concomitant decrease of transactivator functions and increase of
transinhibitor activity is responsible for ECM dysfunction, leading to aging/senescence in dermal fibroblasts.
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INTRODUCTION
Dermal fibroblasts are crucial cells in skin homeostasis and
are responsible for the synthesis of extracellular matrix (ECM)
components. Fibrillar collagens (type I, III, V) represent
almost 80% of dermis constituents and confer mechanical
resistance (Chung et al., 2001). Skin elasticity is based on
arrangements of numerous fibers such as microfibrils of
fibrillin, cross-linked elastin, or fibulin (Labat-Robert, 2003;
Naylor et al., 2011). The third category includes glycosami-
noglycans and hyaluronic acid, which maintain a suitable
skin hydration (Oh et al., 2011). These three types of
constituents are correctly regulated during the juvenile
period. Under irregular remodeling of these groups of
molecules, the dermis displays alterations and disorganiza-
tions, resulting in skin aging. Among these components, type
I collagen is the major isotype of skin dermis. This molecule is
made up of two a1(I) chains and one a2(I) chain, respectively,
encoded by the COL1A1 and COL1A2 genes, which are
coordinately regulated in majority by common transcription
factors. Among these, Sp1, Sp3 (specific proteins 1 and 3;
Chen et al., 1998), CBF (CCAAT-binding factor; Saitta et al.,
2000; Lindahl et al., 2002), and hc-Krox (human collagen-
Kru¨ppel box; Kypriotou et al., 2007) were described as
transactivators that bind to the 112/61-bp sequence of the
COL1A1 promoter in vivo and are involved in type I collagen
dysregulation.
Various cytokines have been shown to regulate collagen
gene expression in fibroblasts. Among them, TNF-a has been
described as an inhibitor of type I collagen expression in skin
fibroblasts (Verrecchia and Mauviel, 2004), in particular via
NF-kB recruitment (Kouba et al., 1999). NF-kB has been
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described to decrease type I collagen expression by interfer-
ing with Sp1 activation in NIH-3T3 cells on the Col1a1
promoter (Rippe et al., 1999) or with the supplementary
participation of CBF, Sp3, and hc-Krox on the COL1A1 gene
in human primary skin fibroblasts (Beauchef et al., 2012).
In addition, it has been reported that the levels of NF-kB
were increased during oxidative and senescence processes
(Helenius et al., 1996; Salminen and Kaarniranta, 2009;
Rovillain et al., 2011).
Although type I collagen levels are decreased during the
skin aging process, at least partly because of the matrix
metalloproteinase actions (Fisher et al., 2009), little is known
about the involvement of transcription factors regulating
COL1A1 transcription. In the present study, we have tried to
investigate the relative importance of the binding of transcrip-
tional activators and inhibitors in the COL1A1 regulation
during the intrinsic aging process.
RESULTS
Dermal fibroblasts of young individuals express higher amounts
of type I collagen than fibroblasts from older donors
Dermal homeostasis is directly correlated with the youthful-
ness of the skin. Type I collagen, as the major constituent of the
dermis ECM and one target of skin aging, was evaluated. As
shown in Figure 1a, quantification of type I collagen synthesis
was performed in two separate groups aged below and above
51 years. By using a specific ELISA, we compared type I
collagen synthesis from young and old donors’ fibroblasts at 1,
2, and 7 days of culture. Fibroblasts from young subjects
exhibited higher amounts of type I collagen, and the
differences between the two subpopulations are strengthened
all along the 7 days of culture. The type I collagen amounts are
at least 1.5-fold higher in young samples at 2 and 7 days. The
same age-related differences were observed in whole-skin
biopsies and skin fibroblasts in western blot experiments
(Figures 1b and Supplementary Figure S1 online). To assess
whether a transcriptional regulation was involved in such an
effect, the steady-state levels of COL1A1 mRNA were
evaluated. As shown in Figure 1c, higher COL1A1 mRNA
amounts were found in young fibroblasts, indicating that type I
collagen synthesis is governed by a transcription control, as
observed in different physiopathological contexts such as
scleroderma (Ghosh, 2002).
Aging of the fibroblasts alters the pattern of DNA-binding
activity of COL1A1 transactivators, Sp1, Sp3, CBF, and hc-Krox
Because of the decreased type I collagen expression during the
aging process, we aimed to evaluate the potential involvement
of some characterized COL1A1 transactivators. COL1A1 is a
well-known gene to be particularly regulated on its 112/
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Figure 1. Type I collagen synthesis decreases with age in human dermal fibroblasts. Fibroblasts were distributed in two groups: Yg, youngo51 years; and Od,
old 451 years. (a) Cells were cultured for 1, 2, and 7 days. At the end of incubation, a type I collagen ELISA was performed on culture media. The amount of
type I collagen was normalized to the total protein amounts and expressed in mg per mg of total cell layer protein. Left panel, box plots taking into account
of all the individuals for each age group. Right panel, collagen synthesis is presented for each individual with the age indicated (12, 41, etc). (b) Whole-cell
lysates (15 mg) from fibroblasts were probed with anti-type I collagen and anti-b-tubulin antibodies in western blot assays. Densitometric analyses were
performed with the ImageJ software. The collagen I/b-tubulin ratio are presented as box plots, and statistical significance was assessed using the Mann–Whitney
U test, *Po0.05. (c) Total RNAs were reverse-transcribed into cDNA, and real-time PCR assay was performed to determine COL1A1 mRNA levels. Data of
(a) and (b) from four experiments are represented as box plots. Statistical analyses were performed with the Mann–Whitney U test, *Po0.05.
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61-bp promoter sequence, especially by Sp1, Sp3, CBF, and
hc-Krox transcription factors (Kypriotou et al., 2007; Beauchef
et al., 2012). As a consequence, gel retardation assays were
performed using several DNA probes in order to compare the
different age groups. The data highlighted a decrease of the
binding activities of Sp3 and Sp1 on the enhancer 1 probe
(Enh1) as aging proceeds (Figure 2a, for the characterization of
the complexes, see Supplementary Figure S2 online). When
using a probe corresponding to the 112/61-bp promoter of
COL1A1 (Beauchef et al., 2012), strong inhibitions of the
binding activities of Sp1, CBF, and hc-Krox with age were
detected (Figure 2b and Supplementary Figure S2 online).
These results are consistent with the increase of mRNA and
protein levels of the CBF competitor Cux1 with age
(Supplementary Figure S3 online; Fragiadaki et al., 2011).
Conversely, western blot analysis of hc-Krox revealed that
during the aging process there is a downregulation of about 2-
fold in its expression, which strictly correlates with type I
collagen synthesis and hc-Krox binding inhibition (Figure 2c
and Supplementary Figure S2 online).
As a conclusion, downregulation of type I collagen
production observed during aging correlates with the decrease
in the interactions of hc-Krox, CBF, Sp1, and Sp3 with their
cis-responsive elements in the 112/61-bp COL1A1 pro-
moter, and an increased expression of Cux1 inhibitor.
Aged fibroblasts display higher amounts and binding activity
of NF-jB than young individuals
Having delineated the binding activity variations of transac-
tivators to COL1A1 promoter, we next investigated the
potential implications of transinhibitors of COL1A1. Whole-
cell lysates from different donors were subjected to western
blot experiments, and the data revealed that the p65 subunit
of NF-kB was more expressed in skin fibroblasts from aged
persons (Figure 3a). In addition, electromobility shift assays
(EMSAs) with a NF-kB consensus probe demonstrated that the
DNA–protein complexes involving NF-kB subunits (p50, p65)
were prevalent in samples from aged skin fibroblasts, and that
the aging process is proportionally correlated with the NF-kB
binding activity, i.e., fibroblasts from aged donors display a
higher NF-kB binding activity compared with those from
younger donors (Figure 3b, for the characterization of the
complexes, see Supplementary Figure S2 online). Aging affects
both p50 and p65 DNA-binding activities, as evidenced in
antibody interference EMSAs (Figure 3c) where the p65 antibody
produced a decrease of the p65 binding activity, suggesting that
the antibody targets the DNA-binding domain; however, a p50
supershift was detected when a p50 antibody was used.
Furthermore, this increase of NF-kB binding detected
during aging can be also induced in fibroblasts from young
donors that were aged by in vitro subculturing of the cells. As
illustrated in Figure 3d, as the passaging number of the
fibroblast cultures increases, there is a concomitant increase
in the NF-kB binding activity.
Quantification of NF-kB proteins complexed to the probe
in EMSA demonstrated a 2.5-fold higher binding in aged
fibroblasts compared with younger cells (Figure 3e).
High amounts of NF-jB in human dermal fibroblasts are found
to inhibit COL1A1 transcription through its short promoter
To determine whether a correlation could exist between the
amounts of NF-kB in the fibroblasts, the inflammatory status,
and the resulting type I collagen synthesis, skin fibroblasts
were first transiently co-transfected with a NF-kB Luc reporter
construct and p65 or p50 expression vectors or the
empty vector pSG5 (control). As shown in Figure 4a, relative
luciferase activities of the NF-kB Luc reporter were found
to be higher (2.5- to 8-fold) in aged skin fibroblasts com-
pared with young skin fibroblasts. Although NF-kB activity
was more elevated in fibroblasts from aged populations, no
particular modulation was detected compared with younger
cells under a p50 or p65 forced expression, because of
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Figure 2. The DNA-binding activity of the type I collagen transactivator–specific proteins 1 and 3 (Sp1, Sp3), CCAAT-binding factor (CBF), and human
collagen-Kru¨ppel box (hc-Krox) are decreased during aging of the fibroblasts. Nuclear extract proteins from human dermal fibroblasts of different ages
were analyzed by electromobility shift assay (EMSA; 7.5 mg per lane) with (a) an Enh1 probe and (b) a 112/61-bp COL1A1 probe. Arrows indicate the
complexes formed between DNA probes and nuclear proteins. (a, b) Ages are indicated. (c) Nuclear extracts (15 mg per lane) from fibroblasts were probed
with anti-hc-Krox and anti-b-tubulin antibodies in western blot experiments. A representative experiment is presented. Densitometric analyses were performed
with the ImageJ software. The hc-Krox/b-tubulin ratios are presented as box plots, and statistical significance was assessed using the Mann–Whitney U test,
*Po0.05.
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already high endogenous levels. By contrast, in young skin
fibroblasts, forced expression of p65 provokes a 2-fold
increase in the transcription activity of the reporter gene,
indicating that the p65 overexpression overcomes the
endogenous p65 levels in younger fibroblasts and produces
as a result a transcriptional function.
In parallel experiments, dermal fibroblasts were trans-
fected with a 112/þ28-bp COL1A1 reporter together with
expression vectors encoding p65 or p50 subunits of NF-kB. In
such conditions, the higher transcription activities of the short
COL1A1 promoter were detected in cells from a younger
generation in basal conditions (Figure 4b). As in Figure 4a,
younger fibroblasts were more sensitive to NF-kB forced
expressions, and this clearly leads to a huge decrease in
transcriptional activity of COL1A1. An overexpression of p65
or p50 subunits of NF-kB was shown to decrease the
promoter activity approximately 2-fold compared with
control cells in the younger population. In the same vein
and as in Figure 4a, older cells did not respond to p65 and
p50 induction because high amounts of NF-kB are constitu-
tively present in aged cells, resulting in the absence of a
transcription effect on the COL1A1 Luc reporter.
As a conclusion, these results demonstrate unambiguously
that the amounts of NF-kB in the fibroblasts determine the
extent of the decrease in type I collagen production and also
the sensitivity to inflammatory signals.
The p65 forced expression induces senescence in skin
fibroblasts from young and aged individuals
To verify the pro-aging effect of NF-kB, which is associated
with decreased collagen synthesis, a senescence-associated
b-galactosidase (SA-b-gal) assay on young and aged fibro-
blasts under a p65 forced expression was carried out
(Figure 5). The specific blue staining, linked to senescence
of the cells, was observed in each type of fibroblast
regardless of the age range (23% of senescent cells in young
fibroblasts). However, the staining was found to be more
pronounced and affected many more cells in fibroblasts from
aged skin donors (31% of SA-b-gal-positive cells). Moreover,
in both young and aged fibroblasts, p65 forced expression
promoted the appearance of further senescent cells and
significantly induced a deeper blue staining by doubling the
number of positive cells in the young and old groups (52%
and 70%, respectively). Microscopic analyses also reveal
differences in fibroblast morphology between the different
subpopulations in the sense that aged cells or cells in which
p65 overexpression was induced present a greater size, and
are polygonal with some extensions of the cytoplasmic
membrane—all these features being usually observed in
senescent cells. By contrast, the morphology of the fibroblasts
from younger individuals transfected with the pSG5 control
vector is typical and fusiform, indicating that the shape
changes are not due to the transfection of the cells.
Age: years
Age: years
p65
β-Actin
43
44 69 76 78
p65
p65
p50
p65
p50
p65
Passages
18 yo
5
NF-κB probeNF-κB probe
NF-κB probe
9 15
p50
p50
p50 Antibody
p65 Antibody
250
Yg
Od
200
150
100
50
0
*
Qu
an
tifi
ca
tio
n 
of
 N
F-
κ
B
bi
nd
in
g 
(ar
bit
rar
y u
nit
s)
–
– –
– – –
––
+
+ +
+
Nonspecific
p50 SS p50 SS
30 yo 71 yo
67 71
Figure 3. NF-jB levels are enhanced with age and its binding activity increases as well. (a) Twenty micrograms of nuclear extracts of human dermal fibroblasts
of different ages were probed with anti-p65 and anti-actin antibodies in western blot experiments. (b, c, d) Nuclear extracts (7.5 mg per lane) were submitted to
electromobility shift assay (EMSA) using a NF-kB consensus probe. DNA–protein complexes are indicated with arrows. (c) Nuclear extracts from subjects
aged 30 and 71 years (yo) were pre-incubated with anti-p65 and anti-p50 antibodies before incubation with the NF-kB probe; complexes are indicated
with arrows. (d) Nuclear extracts from an individual of the first group (18 years old) were collected at passages 5, 9, and 15 and submitted to EMSA using
a NF-kB probe. (e) NF-kB binding activities of young (Yg) and old (Od) donors were quantified (n¼ 4 for each age range) by using the ImageJ software
and are expressed as box plots as described in Figure 1. p50 SS, p50 supershift.
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DISCUSSION
Skin aging results in intrinsic and extrinsic aging. Extrinsic aging
is the consequence of external events (UV, environmentals;
Tanaka et al., 2010), which, in most of the cases, accentuate
dysregulations occurring during intrinsic aging. In various
models, intrinsic skin aging is described as the occurrence of
decreased expressions of several markers, mainly ECM
components (Carrino et al., 2003), whereas matrix metallopro-
teinases are by contrast stimulated (Dasgupta et al., 2009;
Quan et al., 2009). Among these matrix components, type I
collagen remains the most represented (480% of the dermal
collagens). The structure and amounts of type I collagen are
known to be dysregulated during the aging process, partly
owing to a transcriptional control. The underlying aims of this
study were to demonstrate whether type I collagen down-
regulation observed between young and older populations of
skin fibroblasts could result from a dysfunction in the
recruitments of COL1A1 transactivators and transinhibitors.
First, we focused on the regulation of type I collagen
expression by evaluating excreted proteins and determining
the steady-state amounts of COL1A1 mRNAs synthesized by
skin fibroblasts from young and older donors. As expected,
type I collagen expression decreased as aging proceeded, as
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Figure 5. The p65 subunit of NF-jB induces senescence in human dermal fibroblasts. Human dermal fibroblasts from young (Yg) and old (Od) donors
were transiently transfected with 1 mg per 1 106 cells of a vector encoding the p65 subunit cDNA or the empty vector (pSG5). After transfection, the cells were
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and presented as a graph. Statistical analyses were performed with the Student’s t-test, ***Po0.001. Bar¼ 100mm; for the higher magnification
(indicated by arrows), bar¼15 mm.
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Figure 4. NF-jB and COL1A1 transcription activities are differentially
regulated in young and old human dermal fibroblasts. Human dermal
fibroblasts from young and old donors were transiently transfected overnight
with 1 mg per 1106 cells of a vector encoding the p65 or the p50 subunit
cDNA or the empty vector (pSG5) together with 2 mg per 1 106 cells of
pSV40-b-gal, and with (a) 2 mg per 1106 cells of the NF-kB Luc construct or
(b) the 112/þ28-bp COL1A1 reporter construct. Values are the mean of
triplicate samples±SD of a representative experiment. Values are expressed
as relative luciferase unit (RLU). Statistical analyses were performed with the
Student’s t-test, *Po0.05; **Po0.01; ***Po0.001, when the comparison was
made between young and old subjects, and #Po0.05 when different cases
from the same group are compared.
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previously described. Indeed, the fibroblast distribution in the
two age groups (under and above 51-year-old) allowed us to
distinguish discrepancies in the binding activities of three zinc-
finger transcription factors (Sp1, Sp3, and hc-Krox) and of CBF,
as there was a pronounced decrease, apparently of the same
magnitude, of the DNA-binding activity for all these transacti-
vators of COL1A1 in aged fibroblasts compared with the
younger ones. All these factors were previously demonstrated
to be potent transactivators acting on basal and amplified
transcription of the COL1A1 short promoter (Chen et al., 1998;
Saitta et al., 2000; Verrecchia et al., 2001; Ihn et al., 2006;
Kypriotou et al., 2007). In that sense, we previously demon-
strated that hc-Krox exerted a stimulating effect on type I
collagen at both protein synthesis and mRNA steady-state
levels of COL1A1 and COL1A2 in foreskin, and in healthy and
scleroderma fibroblasts. Gain- and loss-of-function experi-
ments demonstrated that hc-Krox upregulate COL1A1 tran-
scription through a 112/61-bp sequence. Furthermore, the
112/61-bp sequence was not only found to bind specifi-
cally hc-Krox but also Sp1, as well as CBF transcription factors
through their relative responsive elements, and could also
interact together and with Sp3 (Kypriotou et al., 2007;
Beauchef et al., 2012). In this context, the two zinc fingers,
Sp1 and Sp3, act as transactivators of type I collagen
expression in normal and scleroderma fibroblasts via the
112-bp region of COL1A1 (Beauchef et al., 2012).
By contrast, NF-kB has been described as an inhibitor of
COL1A1 and COL1A2 expressions in various models (Rippe
et al., 1999; Beauchef et al., 2012). We previously demon-
strated that NF-kB downregulates COL1A1 expression by a
transcriptional control involving the 112/61-bp sequence,
despite no existing kB consensus sequence. Moreover, we
found that Sp1/Sp3/hc-Krox and NF-kB bind and/or are
recruited on this proximal promoter via protein interactions
between Sp1/Sp3/hc-Krox and p65, and are necessary to
mediate the NF-kB inhibitory effect on COL1A1 in skin
fibroblasts (Beauchef et al., 2012).
In our present study, NF-kB displayed a prominent
increase in its DNA-binding activity during the aging
process, which is in agreement with the work of Salminen
and Kaarniranta (2010). In addition, this binding activity
enhancement of NF-kB was also induced by subculturing
young dermal fibroblasts that mimic a propitious context
of replicative senescence. Actually, these effects could be
the consequences of oxidative stress accumulation and
DNA damage, enabling a sustained activation of the NF-kB
system. Several studies demonstrated the role of NF-kB in
matrix metalloproteinase expression as well, which was
responsible for collagen degradation (Mine et al., 2008).
Besides, we observed that a p65 or a p50 forced expression
triggering an increased NF-kB activity (NF-kB Luc reporter)
accompanied a downregulation of type I collagen expres-
sion only in young fibroblasts, whereas in aged cells NF-kB
overexpression was not able to significantly alter the
reduced collagen synthesis or NF-kB Luc activity. To
explain these discrepancies in the NF-kB transcription
function in young and senescent fibroblasts, this impair-
ment, which is specific to aged cells, should be attributable
to already elevated endogenous amounts of active NF-kB,
as demonstrated by our data, which would overcome, in
fine, the NF-kB forced expression effects.
In the same way, particular attention to NF-kB impacts on
COL1A1 transcriptional activity has been evidenced. Thus,
COL1A1 transcriptional activities of both controls in the two
subpopulations of fibroblasts correlated with the changes
observed in type I collagen expression, i.e., the lowered type I
collagen protein expression is detected in aged individuals and
resulted in a transcription control, as the transcription activity
of the 112-bp promoter of COL1A1 is decreased compared
with younger cells. Similarly, these results are consistent with
the amounts and endogenous activities of NF-kB observed in
aged fibroblasts. In that sense, as observed in NF-kB Luc
reporter assays, overexpression of NF-kB subunits only
affected the COL1A1 transcription activity of the younger
cells. Our results suggest that aging-dependent regulation of
type I collagen is at least partly due to NF-kB action on the
type I collagen promoter and also due to its significant amount
of enhancement in aged cells. These data are also corrobo-
rated by the SA b-gal activity (Kurz et al., 2000), determined
after p65 forced expression experiments in young and aged
cells, which further induces senescence in the cells when
compared with their respective controls. In addition, the blue
staining was more pronounced in aged cells, suggesting that
senescence occurs with lower collagen synthesis. Our data
obtained in primary cultured skin fibroblasts are in agreement
with prior studies (Rovillain et al., 2011).
Here, we demonstrated that human skin fibroblasts have
lowered Sp1 binding activity on cis-responsive elements of
COL1A1 promoter during the aging process, suggesting a
potent loss of its transcriptional activity. Considering that older
fibroblasts displayed senescence as well, our results are not in
agreement with the study of Kim and Lim (2009), which
demonstrates that Sp1 is a mediator of senescence, because of
its stimulation by ERK1/2, and that it induces p21 expression.
Furthermore, other reports argued that Sp1 was essential for
p16 expression in human diploid fibroblasts during senes-
cence (Wu et al., 2007). Taken together, we could imagine
that the Sp1 recruitment on target genes could depend on
switches between signaling pathways, especially those parti-
cipating in senescence and matrix anabolism. Besides, other
studies revealed the importance of Sp1 in the global decrease
in gene transcription reported during aging of the cells and
tissues (Oh et al., 2007). In our case, a Sp1 knockdown did not
significantly change the senescence status of the fibroblasts,
when evaluated by a SA-b-gal assay (data not shown).
The binding activity of CBF, another transactivator
recruited on COL1A1 (Kypriotou et al., 2007), was seen to
decrease with aging. Our data strictly agreed with the study
of Matuoka and Chen (2002), which highlighted the
importance of transcriptional regulation by the CCAAT
box–binding factor, and demonstrated that this factor
decreased during aging and that its dominant negative
could induce senescence (Matuoka and Chen, 1999, 2002).
These data must be correlated with the increase of Cux1
expression in aging fibroblasts, which was described by
Fragiadaki et al. (2011), as a negative regulator of CBF and
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an inhibitor of the type I collagen synthesis. In the
same vein, our previous study showed an increase of the
hc-Krox DNA binding on COL1A1 promoter, particularly in
scleroderma fibroblasts, associated with their higher
amounts of type I collagen (Kypriotou et al., 2007). From
the present study, the inverse correlation is observed where
aging is characterized by a downregulation of type I
collagen synthesis, which is associated with lower expres-
sion and binding activity of hc-Krox leading to a reduced
transcription of COL1A1.
As a conclusion, this study demonstrated that the
variations of expression during aging of the main dermal
component, type I collagen, are subjected to a regulation
depending on the relative amounts and binding ability of
transcriptional activators, such as Sp1, Sp3, CBF, and hc-
Krox, by their recruitment on the COL1A1 promoter.
However, downregulation of COL1A1 transcription that
occurs during aging is also due to the prevalence of the
NF-kB activity, and probably due to Cux1, the former being
described as a negative regulator of the renewal of dermal
connective tissue, at least partly by inhibiting COL1A1
expression. In addition, the 112/61-bp COL1A1 promoter
sequence could be assimilated as a responsive cis-element
sensor of senescence initiation.
MATERIALS AND METHODS
Cell culture
Human dermal fibroblasts were obtained from skin breast biopsies of
caucasian donors (from 17- to 78-year-old), which were provided by
Dr M. Jolivet (Department of Reconstructive Surgery, St-Martin
Clinic, Caen, France) and by Johnson&Johnson laboratories (John-
son&Johnson Sante´ Beaute´ France, Campus de Maigremont, 27100
Val de Reuil, France). Fibroblast isolation and culture were
performed as previously described (Attia et al., 2011). Cells were
passaged with a trypsin (0.05%) and EDTA (0.25mM) solution after
reaching confluency. Cells were used between passages 3 and 15.
Western blot analyses and type I collagen ELISA
At the end of the incubations, cells were washed and the fibroblasts
were harvested in radioimmunoprecipitation assay buffer supplemen-
ted with leupeptin (1mlml1), aprotinin (1mlml1), and pepstatin
(1mlml1; Roche Diagnostics, Meylan, France). Protein concentration
was measured using a Bio-Rad Protein Assay Kit (Bio-Rad Laboratories,
Marnes-La-Coquette, France). Type I collagen was evaluated in the
culture media with the CICP MicroVue Bone Health kit, according to
the manufacturer’s instructions (TECOmedical, Charenton, France),
and was normalized to the cell layer protein amounts.
For western blots, protein extracts (20mg) were fractionated by
SDS–PAGE and processed as previously described (Kypriotou et al.,
2007; Beauchef et al., 2012).
The following primary antibodies were used: anti-b-actin, 1/500;
anti-p65, 1/250; anti-b-tubulin, 1/300 (Tebu-bio, Le Perray en
Yvelines, France); anti-type I collagen, 1/1500; and anti-hc-Krox,
1/300 (Novotec, Lyon, France). Subsequently, membranes were
reacted with specific secondary horseradish peroxidase–conju-
gated antibody. The signals were revealed using Western Light-
ning Chemiluminescence Reagent Plus (Perkin Elmer Life
Sciences, Courtaboeuf, France).
RNA extraction and real-time reverse-transcriptase–PCR
Total RNAs and real-time reverse-transcriptase–PCR from cultured
fibroblasts were carried out as previously described (Duval et al.,
2011). Specific primers (Eurogentec, Angers, France) targeting
COL1A1 (sense, 50-CACCAATCACCTGCGGTACAGAA-30; anti-
sense, 50-CAGATCACGTCATCGCACAAC-30) and RPL13 (Ribosomal
protein L13; sense, 50-GAGGTATGCTGCCCCACAAA-30; antisense,
50-GTGGGATGCCGTCAAACAC-30) cDNAs were used. Results
were normalized to RPL13 cDNAs used as a reference.
Luciferase reporter assays
Fibroblasts were passaged using trypsin at confluency and then
distributed in Eppendorf tubes (1 106 cells per 1.5-ml tube). Cells
were centrifuged for 10minutes at 200 g and transfected using the
AMAXA Nucleofectors apparatus (Lonza, Ko¨ln, Germany), accord-
ing to the manufacturer’s instructions. In a first type of transient
transfection experiments, we used the COL1A1 short promoter
(112/þ 28bp) associated with the luciferase reporter gene (pro-
vided by Dr R Widom). In the second type of transient transfections,
the transcription activity of NF-kB was evaluated with a NF-kBLuc
reporter plasmid. In both cases, a pSV40/b-gal plasmid (2mg) was co-
transfected as a control of transfection efficiency. According to the
experiments, 2mg of the luciferase reporter gene constructs were
mixed with 1mg of the pSG5 expression vector containing p65 or p50
cDNA or not (control), and 1 106 cells resuspended in 100ml of
nucleofection solution. After seeding, the culture medium was
replaced by a fresh one 6 hours post transfection. After 12 hours,
the medium was removed and the cells were washed twice with ice-
cold PBS and harvested in lysis buffer. Luciferase and
b-galactosidase activities, as well as the protein amount, were
determined as previously described (Ghayor et al., 2000).
Nuclear extracts and EMSA
Nuclear extracts were prepared using a mini preparation procedure
(Andrews and Faller, 1991). For EMSAs, specific probes were end-
labeled with [a-32P]dATP (Perkin Elmer Life Sciences) using T4
polynucleotide kinase (Promega, Charbonnie`res-Les-Bains, France).
The sequence of the probes used are as follows: Enh1 (enhancer 1)
binding both Sp1 and Sp3 (Ghayor et al., 2000), the 112/61-bp
COL1A1 probe including CBF, Sp1, and c-Krox binding sites
(Kypriotou et al., 2007), and the NF-kB consensus binding site
(sense: 50-AGTTGAGGGGACTTTCCCAGGC-30). In all, 7.5 mg of
skin fibroblast nuclear extracts were processed as previously
described (Kypriotou et al., 2007; Beauchef et al., 2012).
SA b-gal staining
SA b-gal staining (Lee et al., 2006) was performed using the
Senescent-associated b-galactosidase staining kit (Cell Signaling
Technology, Saint Quentin Yvelines, France) according to the
manufacturer’s instructions.
Statistical analyses
All the experiments were repeated at least three times each with
different donors and similar results were obtained. Data were
expressed as means±SD. Statistical significance was assessed using
the Mann–Whitney U test (box-plots) or Student’s t-test. Only P-
values o0.05 were considered significant. ***Po0.01; **Po0.01;
*Po0.05 or #Po0.01; ##Po0.01; ###Po0.05.
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